Medblue — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Sparta Biomedicalspartabiomedical.cominDec 2021
Sparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology.
BiotechHealthtechMedical DevicesMadison, US
Dushyanth Surakanti(Executive Officer, Director)inKen Gall(Director)Dimitrios Angelis(Executive Officer, Director)Sean Fontenot(Director)
Co-investorsDuke Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




